Status:
COMPLETED
"Night Vision and Carotenoids"
Lead Sponsor:
Robert Davis
Collaborating Sponsors:
Davis EyeCare
Conditions:
Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Vision at twilight and night is more difficult and dangerous for the entire population, even more so for the elderly and especially for the elderly with degenerative disease. Multiple worldwide labora...
Detailed Description
This is a study of the physiological function of the eyes at night. However, the risk of automobile injury or fatality (driver, passenger or pedestrian) associated with motor vehicle accidents has bee...
Eligibility Criteria
Inclusion
- No significant supplementary carotenoids within last 10 weeks. Without significant media opacity, cataract or congenital / acquired retinal disease other than atrophic AMD or diabetic retinopathy. Minimum 20/25 to enroll.
Exclusion
- Unwilling or medically / psychiatrically unable to take part in a 6 month study.
- Recent ophthalmologic surgery or treatment.
- Tricare, Retirees \& Enlisted Navy Personnel excluded. Already taking an OTC product to improve their night vision (containing carotenoids, polyphenols like bilberry).
Key Trial Info
Start Date :
February 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2020
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04741763
Start Date
February 13 2018
End Date
August 20 2020
Last Update
February 5 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Captain James A. Lovell Federal Health Care Center (FHCC)
North Chicago, Illinois, United States, 60064
2
Davis EyeCare
Oak Lawn, Illinois, United States, 60453